Colaborative Research on Anti-HIV Triterpenoids

抗HIV三萜类化合物的合作研究

基本信息

  • 批准号:
    09044339
  • 负责人:
  • 金额:
    $ 1.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

A series of lupane-type triterpenoic acid derivatives were synthesized and evaluated for their inhibitory activity against HIV-1 replication in acutely infected H9 cells, based on the fact that betulinic acid (1) and dihydrobetulinic acid (9) were identified as anti-HIV agents. Among the derivatives, 3-O-(3 ', 3 '-dimethylsuccinyl)-betulinic acid (3) and 3-O-(3 ', 3 '-dimethyl-succinyl)-dihydrobetulinic acid (11) both demonstrated extremely potent inhibitory activity with EC_<50> values of< 0.00035 muM.They exhibited remarkable in vitro therapeutic index (TI.) values of >20,000 and >14,000, respectively. 3-O-(3', 3'-Dimethylglutaryl)-betulinic acid and -dihydrobetulinic acid(12), 3-O-diglycolyl-betulinic acid and -dihydrobetulinic acid and 3-O-glutaryl- betulinic acid were also potent inhibitors of HIV replication with ED_<50> values ranging from 0.01 to 0.0023 muM and T.I.values from 1,017 to 2,344. In addition, compounds 1 1 and 12 are also active against HLV replica-tion in a monocy … More te cell line and n peripheral blood mononuclear cells (PBMCs). Our in vitro assay indicated that these compounds are not inhibitors on HIV- 1 reverse transcriptase, whereas they inhibited syncytia formation completely in a concentration range of 20 - 40 mug/mL.However, 3-O-(2', 2'-dimethylsuccinyl)-betulinic acid (2) was also found to be an inhibitor of HIV-induced membrane fusion with IC_<100> value of 20mutg/mL, though it displayed significantly lower anti-HIV activity than foregoing compounds with ED_<50> value of 2.7 muM and T.l. values of 5.9. This observation indicated that another mechanism(s) of action other than inhibition of syncytia formation could be involved in the anti-HIV activity shown by these compounds. Compound 3 was not active in the MAGI assay, suggesting that it inhibit HIV replication at a late stage of the viral life cycle, such as after viral protein synthesis.On the other hand, oleanolic acid was identified as an anti-HIV principle from several plants, including Rosa woodsii (leaves), Prosopis glandulosa (leaves and twigs), Phorodendron juniperinum (whole plant), Syzygium claviflorum (leaves), Hyptis capitata (whole plant), and Terniroemia gymnanthera (aerial part). It inhibited HIV- 1 replication in acutely infected H9 cells with an EC_<50> value of 3.7 muM, and inhibited H9 cell growth with an IC_<50> value of 47.8 muM [therapeutic index (T.I.) 12.8]. Pomolic acid, isolated from R.woodsii and H.capitata, was also identified as an anti-HIV agent (EC_<50> 3.0 muM, T.I.16.6). Although ursolic acid did show anti-HIV activity (EC_<50> 4.4 muM), it was slightly toxic (IC_<50> 14.3 muM, T.I.3.3). Based on these results, we examined anti-HLV the activity of oleanolic acid- or pomolic acid-related triterpenes isolated from several plants. In addition, we previously demonstrated that derivatives of betulinic acid, isolated from the leaves of S.claviflum as an anti-HIV principle, exhibited extreme potent anti-HIV activity. Accordingly, we prepared derivatives of oleanolic acid, and evaluated their anti-HIV activity. Among the oleanolic acid derivatives, 3-O-(3', 3'-dimethylsuccinyl)-oleanolic acid demonstrated most potent anti-HIV activity, with an EC_<50> value of 0.00086 muM and a T.I.value of 22,400.Though ursolic acid is slightly toxic against H9 cells, it shows similar level of anti-HIV acitivity to that of oleanolic acid. In addition, the structure of ursolic acid is closely correlated with oleanolic acid and betulinic acid, hence it is regarded as a potential lead for anti-HIV agent. Therefore, similar modification of ursolic acid, and evaluated their anti-HIV activities. 3-O-diglycoryl-uroslic acid demonstarated relatively potent anti-HIV activity with an EC_<50> value of 0.31 muM and a T.I.value of 155.5. Hoever, anti-HJV activities for other derivatives, including 3,3-dimethysuccinyl derivative, were not potent as corresponding betulinic acid and oleanolic acid derivatives. Less
基于β-苯甲酸(1)和二氢苯甲酸(9)的事实,将一系列针对HIV-1 y感染的H9细胞的不自越活性合成了一系列lupane型酸衍生物,3-o(3',3'-二甲基二酸) - 尿酸(3)和3-o-(3' - 二甲基 - 糖基)-Dihydrobetulinic 11)均表现出具有EC_ <50>值的极有效的抑制性活性<0.00035妈妈的酸和 - 二氢蛋白酸(12),3-o-二甲基 - 甲基 - 甲基酸酯和二氢蛋白酶酸和3-o-戊磺胺酸盐酸盐和二羟基苯甲酸甲酸的高核酸的高度复制,范围为0.01至0.0023 MUM,T.I.VALUEs从1,017到2,344。不是HIV-1逆转录酶的抑制剂,而它们完全抑制合成症的形成在20-40 ml的浓度范围为20-40 ml.howver,3- O-(2',2',2'-二甲基糖蛋白基) - 蛋白酸(2)成为hiv-niv的抑制剂,其eD_ <50>值为2.7妈妈和T.L的抑制剂。 HESE化合物3所示的良好性在MAGI测定中没有活性。 3.7妈妈的值,抑制H9细胞的生长,IC_ <50>值为47.8 MUM [治疗指数(T.I.)12.8]。 3.0妈妈,T.I.16.6)。作为抗HIV原理的链球菌的叶子相应地表现出极端有效的抗HIV活性,我们制备了橄榄酸的衍生物,并评估了其抗HIV活性。 EC_ <50>值为0.00086 MUM,T.I.值为22,400。尽管Ursolic Accids对H9细胞对橄榄酸的毒性略有毒性,与橄榄酸的含量密切相关,并与橄榄酸和腰酸抗酸密切相关,并评估了其抗HIV活性. -HIV ACTIVITY WITH AN EC_ <50> Value of 0.31 Mum and a T.I.Value of 155.5. CCINYL Derivative, Were Not Potent as CorRespanding Betualinic ACID and Olenolic Acidid Derivatives. Less

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshiki Kashiwada: "Anti-AIDS Agents 30. Anti-HIV Activity of Oleanolic Acid Pomolic Acid and Structurally Related Triterpenes" Journal of Natural Products. 61(9). 1090-1095 (1998)
Yoshiki Kashiwada:“抗艾滋病药物 30。齐墩果酸、泊莫酸和结构相关三萜的抗 HIV 活性”天然产物杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fumio Hashimoto: "Anti-AIDS Agents-XXVII. Syntheis and Anti-HIV Activity of Betulinic Acid and Dihydrobetulinic Acid Derivatives" Bioorganic and Medicinal Chemistry. 5(12). 2133-2143 (1997)
Fumio Hashimoto:“抗艾滋病药物-XXVII。桦木酸和二氢桦木酸衍生物的合成和抗HIV活性”生物有机和药物化学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fumio Hashimoto: "Anti-AIDS Agents-XXVII.Synthesis and Anti-HIV Activity of Betulinic Acid and Dihydrobetulinic Acid Derivatives" Bioorganic and Medicinal Chemistry. 5(12). 2133-2143 (1997)
Fumio Hashimoto:“抗艾滋病药物-XXVII.桦木酸和二氢桦木酸衍生物的合成和抗HIV活性”生物有机和药物化学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KASHIWADA Yoshiki其他文献

KASHIWADA Yoshiki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KASHIWADA Yoshiki', 18)}}的其他基金

Development of anti-HIV agents with dual mechanisms of actions based on triterpenoids as drug discovery templates
以三萜类化合物为药物发现模板,开发具有双重作用机制的抗 HIV 药物
  • 批准号:
    15K07998
  • 财政年份:
    2015
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ethnobotanical research and effective utilization of Mongolian medicinal plants (secondary survey)
蒙古药用植物民族植物学研究及有效利用(二次调查)
  • 批准号:
    26305003
  • 财政年份:
    2014
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Ethnobotanical research and effective utilization of Mongolian medicinal plants
蒙古药用植物的民族植物学研究与有效利用
  • 批准号:
    22406024
  • 财政年份:
    2010
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on betulin and betulinic acid derivatives aimed at developing anti-HIV agents effective against resistant virus
研究桦木醇和桦木酸衍生物,旨在开发有效对抗耐药病毒的抗艾滋病毒药物
  • 批准号:
    22510233
  • 财政年份:
    2010
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anti-HIV Natural Products from the plants Destributed in the Northern Part of Japan
来自日本北部植物的抗 HIV 天然产物
  • 批准号:
    11694321
  • 财政年份:
    1999
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似国自然基金

三萜类化合物对水通道蛋白1调控的分子动力学模拟及活性优化研究
  • 批准号:
    22303035
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
钙调磷脂酶信号介导H2O2调控桦褐孔菌三萜类化合物合成的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
云南升麻根茎中三萜类化合物抗动脉粥样硬化的机制研究
  • 批准号:
  • 批准年份:
    2019
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
氮素调控青钱柳三萜类化合物合成的机制研究
  • 批准号:
    31800528
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
茯苓三萜类化合物合成中相关细胞色素P450基因的鉴定与功能研究
  • 批准号:
    81803667
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of dearomative functionalization strategies for efficient assembly of quassinoid triterpenoids
开发有效组装苦木素三萜类化合物的脱芳香功能化策略
  • 批准号:
    22KJ1772
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Triterpenoids in mitigation of radiation induced acute or delayed inflammation
三萜类化合物可减轻辐射引起的急性或迟发性炎症
  • 批准号:
    10852214
  • 财政年份:
    2022
  • 资助金额:
    $ 1.09万
  • 项目类别:
Identification of transcription factors regulating triterpenoids biosynthesis: towards the elucidation of the biological roles of triterpenoids in legumes
鉴定调节三萜生物合成的转录因子:阐明豆类中三萜的生物学作用
  • 批准号:
    20H02913
  • 财政年份:
    2020
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis and molecular design of glycosyltransferases in the biosynthesis of plant triterpenoids
植物三萜生物合成中糖基转移酶的功能分析和分子设计
  • 批准号:
    19H02921
  • 财政年份:
    2019
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of a yeast strain for production of plant triterpenoids
植物三萜类化合物生产酵母菌株的建立
  • 批准号:
    19K23667
  • 财政年份:
    2019
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了